vs
Side-by-side financial comparison of La Rosa Holdings Corp. (LRHC) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $20.2M, roughly 2.0× La Rosa Holdings Corp.). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -27.4%, a 63.3% gap on every dollar of revenue. On growth, La Rosa Holdings Corp. posted the faster year-over-year revenue change (3.2% vs -10.9%). Over the past eight quarters, La Rosa Holdings Corp.'s revenue compounded faster (72.5% CAGR vs -15.0%).
V. La Rosa and Sons Macaroni Company was founded in 1914 by Vincenzo La Rosa, a Sicilian immigrant. The company eventually became one of the largest regional brands in the United States producing over 40 varieties of pasta.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
LRHC vs SBC — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $20.2M | $39.6M |
| Net Profit | $-5.5M | $14.2M |
| Gross Margin | 8.4% | 73.1% |
| Operating Margin | -24.7% | 32.5% |
| Net Margin | -27.4% | 35.9% |
| Revenue YoY | 3.2% | -10.9% |
| Net Profit YoY | -125.7% | 117.2% |
| EPS (diluted) | $-5.44 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $39.6M | ||
| Q3 25 | $20.2M | $43.4M | ||
| Q2 25 | $23.2M | $43.4M | ||
| Q1 25 | $17.5M | $47.3M | ||
| Q4 24 | $17.7M | $44.4M | ||
| Q3 24 | $19.6M | $53.1M | ||
| Q2 24 | $19.1M | $53.1M | ||
| Q1 24 | $13.1M | $54.8M |
| Q4 25 | — | $14.2M | ||
| Q3 25 | $-5.5M | $12.8M | ||
| Q2 25 | $78.4M | $2.5M | ||
| Q1 25 | $-95.7M | $21.5M | ||
| Q4 24 | $-5.1M | $6.5M | ||
| Q3 24 | $-2.5M | $2.8M | ||
| Q2 24 | $-2.3M | $18.5M | ||
| Q1 24 | $-4.6M | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | 8.4% | 70.6% | ||
| Q2 25 | 8.0% | 69.2% | ||
| Q1 25 | 8.8% | 79.7% | ||
| Q4 24 | 8.9% | 76.3% | ||
| Q3 24 | 8.3% | 81.5% | ||
| Q2 24 | 8.3% | 74.2% | ||
| Q1 24 | 8.9% | 72.1% |
| Q4 25 | — | 32.5% | ||
| Q3 25 | -24.7% | 36.6% | ||
| Q2 25 | -10.6% | 33.6% | ||
| Q1 25 | -26.7% | 51.1% | ||
| Q4 24 | -17.1% | 10.6% | ||
| Q3 24 | -8.9% | 26.1% | ||
| Q2 24 | -9.7% | 51.4% | ||
| Q1 24 | -35.0% | 44.6% |
| Q4 25 | — | 35.9% | ||
| Q3 25 | -27.4% | 29.6% | ||
| Q2 25 | 337.8% | 5.7% | ||
| Q1 25 | -546.5% | 45.4% | ||
| Q4 24 | -28.7% | 14.7% | ||
| Q3 24 | -12.5% | 5.3% | ||
| Q2 24 | -12.2% | 34.8% | ||
| Q1 24 | -35.1% | 34.2% |
| Q4 25 | — | $0.15 | ||
| Q3 25 | $-5.44 | $0.12 | ||
| Q2 25 | $15.25 | $0.02 | ||
| Q1 25 | $-5.86 | $0.21 | ||
| Q4 24 | $28.54 | $0.05 | ||
| Q3 24 | $-16.49 | $0.03 | ||
| Q2 24 | $-12.49 | $0.20 | ||
| Q1 24 | $-0.35 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.0M | $164.1M |
| Total DebtLower is stronger | $642.8K | $42.8M |
| Stockholders' EquityBook value | $1.6M | $248.3M |
| Total Assets | $21.7M | $380.4M |
| Debt / EquityLower = less leverage | 0.41× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $164.1M | ||
| Q3 25 | $4.0M | $127.4M | ||
| Q2 25 | $5.1M | $152.7M | ||
| Q1 25 | $2.9M | $132.1M | ||
| Q4 24 | $1.4M | $125.0M | ||
| Q3 24 | $1.8M | $137.4M | ||
| Q2 24 | $1.6M | — | ||
| Q1 24 | $1.1M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | $642.8K | $21.1M | ||
| Q2 25 | $644.3K | $7.1M | ||
| Q1 25 | $645.9K | $6.9M | ||
| Q4 24 | $647.6K | $6.6M | ||
| Q3 24 | $649.2K | $823.2K | ||
| Q2 24 | $650.8K | — | ||
| Q1 24 | $652.4K | — |
| Q4 25 | — | $248.3M | ||
| Q3 25 | $1.6M | $248.0M | ||
| Q2 25 | $3.4M | $244.6M | ||
| Q1 25 | $-87.5M | $226.4M | ||
| Q4 24 | $2.6M | $195.1M | ||
| Q3 24 | $5.0M | $205.0M | ||
| Q2 24 | $4.7M | $8.8M | ||
| Q1 24 | $5.6M | $9.0M |
| Q4 25 | — | $380.4M | ||
| Q3 25 | $21.7M | $321.4M | ||
| Q2 25 | $22.9M | $315.3M | ||
| Q1 25 | $21.0M | $284.6M | ||
| Q4 24 | $19.4M | $266.1M | ||
| Q3 24 | $19.7M | $296.5M | ||
| Q2 24 | $18.7M | $19.5M | ||
| Q1 24 | $16.3M | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | 0.41× | 0.09× | ||
| Q2 25 | 0.19× | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | 0.25× | 0.03× | ||
| Q3 24 | 0.13× | 0.00× | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.12× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-1.3M | $52.0M |
| Free Cash FlowOCF − Capex | — | $51.2M |
| FCF MarginFCF / Revenue | — | 129.3% |
| Capex IntensityCapex / Revenue | — | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | — | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $52.0M | ||
| Q3 25 | $-1.3M | $-20.9M | ||
| Q2 25 | $-1.4M | $-8.3M | ||
| Q1 25 | $-3.5M | $1.9M | ||
| Q4 24 | $-1.1M | $-7.3M | ||
| Q3 24 | $-591.6K | $5.0M | ||
| Q2 24 | $-803.1K | $19.2M | ||
| Q1 24 | $-538.3K | $3.7M |
| Q4 25 | — | $51.2M | ||
| Q3 25 | — | $-20.9M | ||
| Q2 25 | — | $-8.6M | ||
| Q1 25 | — | $1.7M | ||
| Q4 24 | — | $-7.9M | ||
| Q3 24 | — | $4.6M | ||
| Q2 24 | — | $18.3M | ||
| Q1 24 | — | $3.0M |
| Q4 25 | — | 129.3% | ||
| Q3 25 | — | -48.3% | ||
| Q2 25 | — | -19.9% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | -17.8% | ||
| Q3 24 | — | 8.7% | ||
| Q2 24 | — | 34.5% | ||
| Q1 24 | — | 5.4% |
| Q4 25 | — | 2.0% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | -0.02× | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LRHC
| Real Estate Residential Brokerage Services | $16.8M | 83% |
| Transferred Over Time | $3.5M | 17% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |